During the past decade, Institut Curie; Oncologie Medicale conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 18 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 8 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Institut Curie; Oncologie Medicale" #1 sponsor was "Hoffmann-La Roche" with 28 trials, followed by "Genentech, Inc." with 4 trials sponsored, "Puma Biotechnology, Inc." with 2 trials sponsored, "Arno Therapeutics" with 1 trials sponsored and "Oncolytics Biotech" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Institut Curie; Oncologie Medicale" #1 collaborator was "Genentech, Inc." with 3 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Austrian Breast and Colorectal Cancer Group" with 1 trials as a collaborator and "Foundation Medicine, Inc." with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Institut Curie; Oncologie Medicale" are "Breast Cancer" (18 trials), "Head and Neck Neoplasms" (2 trials), "Neoplasms" (2 trials), "Ovarian Cancer" (2 trials) and "Sarcoma" (2 trials). Many other conditions were trialed in "Institut Curie; Oncologie Medicale" in a lesser frequency.

Most popular intervention types in "Institut Curie; Oncologie Medicale" are "Drug" (35 trials), "Biological" (3 trials), "Other" (3 trials), "Procedure" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.

The name of intervention was led by "Paclitaxel" (12 trials), "Placebo" (8 trials), "Trastuzumab" (8 trials), "Pertuzumab" (7 trials) and "Docetaxel" (6 trials). Other intervention names were less common.

The vast majority of trials in "Institut Curie; Oncologie Medicale" are 28 trials for "All" genders, 8 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Institut Curie; Oncologie Medicale". undefined are not yet recruiting, 4 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Institut Curie; Oncologie Medicale, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Institut Curie; Oncologie Medicale, 6 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".